FLUORANTHENE METABOLISM - HUMAN AND RAT-LIVER MICROSOMES DISPLAY DIFFERENT STEREOSELECTIVE FORMATION OF THE TRANS-2,3-DIHYDRODIOL

被引:26
作者
DAY, BW
SAHALI, Y
HUTCHINS, DA
WILDSCHUTTE, M
PASTORELLI, R
NGUYEN, TT
NAYLOR, S
SKIPPER, PL
WISHNOK, JS
TANNENBAUM, SR
机构
[1] MIT,DEPT CHEM,DIV TOXICOL,ROOM 56309,CAMBRIDGE,MA 02139
[2] UNIV PITTSBURGH,DEPT ENVIRONM & OCCUPAT HLTH,PITTSBURGH,PA 15238
[3] UNIV PITTSBURGH,DEPT PHARMACEUT SCI,PITTSBURGH,PA 15238
关键词
D O I
10.1021/tx00030a008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The metabolism of the environmental carcinogen fluoroanthene by human liver microsomes was compared to that by liver microsomes from rats treated with Aroclor 1254. Although the human-derived system gave primarily one product, similar metabolites were noted from each system. Enantiomers of the major metabolic product, in both cases the trans-2,3-dihydrodiol, were separated by chiral stationary-phase chromatography. Absolute configurations were assigned by application of the benzoate exciton chirality rules to the CD spectra of the 4-(dimethylamino)benzoyl esters. Liver microsomes from Aroclor 1254-treated rats produced the RR enantiomer of the diol in 75-78% enantiomeric excess, while human liver microsomes produced this enantiomer in only 6-12% excess. The activities of these enantiomers were compared in Salmonella typhimurium strain TM677 mutagenicity assays employing the 9000g supernatant of Aroclor 1254-induced rat liver homogenates. Both the syn- and anti-2,3-dihydrodiol 1,10b-epoxides, which had only been inferred to be metabolites in previous studies, were isolated from the microsomal incubations by preparative reverse-phase HPLC. The evident exceptional aqueous stabilities of these diol epoxides were further examined by half-life determination experiments. Their tetrahydrotetrol hydrolysis products were also noted in the metabolite HPLC profiles. The structures of the tetrahydrotetrols were confirmed by total synthesis.
引用
收藏
页码:779 / 786
页数:8
相关论文
共 36 条
[1]  
AMIN S, 1987, CANCER RES, V47, P3613
[2]   MICROSOMAL ACTIVATION OF FLUORANTHENE TO MUTAGENIC METABOLITES [J].
BABSON, JR ;
RUSSORODRIGUEZ, SE ;
WATTLEY, RV ;
BERGSTEIN, PL ;
RASTETTER, WH ;
LIBER, HL ;
ANDON, BM ;
THILLY, WG ;
WOGAN, GN .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 85 (03) :355-366
[3]   INVITRO DNA-BINDING OF MICROSOMALLY-ACTIVATED FLUORANTHENE - EVIDENCE THAT THE MAJOR PRODUCT IS A FLUORANTHENE N2-DEOXYGUANOSINE ADDUCT [J].
BABSON, JR ;
RUSSORODRIGUEZ, SE ;
RASTETTER, WH ;
WOGAN, GN .
CARCINOGENESIS, 1986, 7 (06) :859-865
[4]   TUMORIGENICITY OF FLUORANTHENE IN A NEWBORN MOUSE LUNG ADENOMA BIOASSAY [J].
BUSBY, WF ;
GOLDMAN, ME ;
NEWBERNE, PM ;
WOGAN, GN .
CARCINOGENESIS, 1984, 5 (10) :1311-1316
[5]   SYNTHESIS OF FLUORANTHENES .2. MICHAEL ADDITION OF VINYL CYANIDE TO FLUORENE-9-CARBOXYLIC ESTERS [J].
CAMPBELL, A ;
TUCKER, SH .
JOURNAL OF THE CHEMICAL SOCIETY, 1949, (OCT) :2623-2626
[6]  
CHANG RL, 1983, CANCER RES, V43, P192
[7]  
DAY BW, 1990, CANCER RES, V50, P4611
[8]   STEREOCHEMISTRY OF THE MAJOR RAT-LIVER MICROSOMAL METABOLITES OF THE CARCINOGEN 7-METHYLBENZ[C]ACRIDINE [J].
DUKE, CC ;
HAMBLEY, TW ;
HOLDER, GM ;
NAVASCUES, CO ;
ROBERTSTHOMSON, S ;
YE, YR .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (05) :546-555
[9]   FORMATION OF DNA AND HEMOGLOBIN ADDUCTS OF FLUORANTHENE AFTER SINGLE AND MULTIPLE EXPOSURES [J].
GORELICK, NJ ;
HUTCHINS, DA ;
TANNENBAUM, SR ;
WOGAN, GN .
CARCINOGENESIS, 1989, 10 (09) :1579-1587
[10]   RELATIVE CONTRIBUTION OF VARIOUS FORMS OF CYTOCHROME-P450 TO THE METABOLISM OF BENZO[A]PYRENE BY HUMAN-LIVER MICROSOMES [J].
HALL, M ;
FORRESTER, LM ;
PARKER, DK ;
GROVER, PL ;
WOLF, CR .
CARCINOGENESIS, 1989, 10 (10) :1815-1821